Randomized comparison between indocyanine green fluorescence plus 99mtechnetium and 99mtechnetium alone methods for sentinel lymph node biopsy in breast cancer

Charlotte Vermersch, Tiphaine Raia-Barjat, Céline Chapelle, Suzanne Lima, Céline Chauleur, Charlotte Vermersch, Tiphaine Raia-Barjat, Céline Chapelle, Suzanne Lima, Céline Chauleur

Abstract

Use of both patent blue and a radioisotope to locate, and reduce the risk of sentinel lymph node (SLN) detection failure in breast cancer is recommended, but drawbacks commonly lead to using only a radioisotope. An alternative method would therefore be valuable. This randomized, controlled study in 99 patients compared SLN detection using 99mtechnetium (Tc) alone versus Tc combined with indocyanine green (ICG). The primary endpoint was the SLN identification rate. The primary outcome measure was the number of patients with <2 SLN detected. One SLN was detected in 44.0% of patients in the dual detection group and 40.8% in the 99mTc alone group (RR = 1.08 (95% CI 0.68; 1.72), p = 0.84). A mean (±SD) of 2.14 ± 1.23 SLN were identified in the dual detection group vs. 1.77 ± 0.85 using Tc alone (p = 0.09). Eight-five (78.7%) SLN were both ICG+ and TC+, 15 (13.9%) ICG+ and Tc-, and 7 (6.5%) ICG- and Tc+. SLN detected were ICG-positive in 92.6% of patients and 99mTc-positive in 85.2% with. No adverse event related to ICG injection was recorded. Dual detection of SLN using ICG and radioisotope is reliable and sensitive but was not superior to isotope alone in successfully locating SLN in our pilot randomized trial.

Conflict of interest statement

The authors declare no competing interests.

References

    1. Saint, P. de V. Recommandations pour la pratique clinique cancer du sein. 342–79 (2005).
    1. Lyman GH, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–7720. doi: 10.1200/JCO.2005.08.001.
    1. HAS, Place de la technique du ganglion sentinelle dans la stratégie diagnostique de l’envahissement ganglionnaire d’un cancer du sein à un stade précoce (2011).
    1. Albo D, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182:393–8. doi: 10.1016/S0002-9610(01)00734-6.
    1. Vermersch C, Raia Barjat T, Perrot M, Lima S, Chauleur C. Place of indocyanine green coupled with fluorescence imaging in research of breast cancer sentinel node. Bull Cancer. 2016;103:381–8. doi: 10.1016/j.bulcan.2016.01.015.
    1. Sugie T, Ikeda T, Kawaguchi A, Shimizu A, Toi M. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis. Int J Clin Oncol. 2017;22:11–7. doi: 10.1007/s10147-016-1064-z.
    1. Jung SY, et al. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial. Ann Surg Oncol. 2014;21:1254–1259. doi: 10.1245/s10434-013-3437-0.
    1. Van der Vorst JR, et al. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol. 2012;19:4104–4111. doi: 10.1245/s10434-012-2466-4.
    1. Wong SL, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001;192:684–689. doi: 10.1016/S1072-7515(01)00858-4.
    1. Sugie T, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013;20:2213–8. doi: 10.1245/s10434-013-2890-0.
    1. Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19:210–3. doi: 10.1016/j.breast.2010.01.014.
    1. Sugie T, et al. Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 2016;23:44–50. doi: 10.1245/s10434-015-4809-4.
    1. Verbeek FPR, et al. Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Breast Cancer Res Treat. 2014;143:333–42. doi: 10.1007/s10549-013-2802-9.
    1. Wilke LG, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491–500. doi: 10.1245/ASO.2006.05.013.
    1. Sanidas EE, de Bree E, Tsiftsis DD. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg. 2003;185:202–10. doi: 10.1016/S0002-9610(02)01367-3.
    1. Lyman GH, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365–83. doi: 10.1200/JCO.2013.54.1177.
    1. Vermersch, C. Etude de faisabilité, évaluant l’intérêt de l’imagerie par fluorescence avec l’ICG associée à la méthode isotopique comme marqueur du ganglion sentinelle dans le cancer du sein (2015).
    1. Motomura K, et al. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol. 1999;29:604–7. doi: 10.1093/jjco/29.12.604.
    1. Zhang X, et al. Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis. PLoS One. 2016;11:e0155597. doi: 10.1371/journal.pone.0155597.
    1. Tagaya N, et al. A novel approach for sentinel lymph node identification using fluorescence imaging and image overlay navigation surgery in patients with breast cancer. World J Surg. 2011;35:154–8. doi: 10.1007/s00268-010-0811-y.
    1. Raia-Barjat T, et al. OSNA (one-step nucleic acid amplification) sentinel lymph node intraoperative molecular analysis in breast cancer: a cost-benefit analysis. Med Oncol. 2014;31:322. doi: 10.1007/s12032-014-0322-z.
    1. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4–16. doi: 10.1002/cncr.21568.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera